FindMyKOL
Clinical trialNCT00377949CompletedObservational

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

NCT00377949 is an observational study sponsored by Georgetown University. As of 21 Nov 2026, it is completed. It studies Pulmonary Arterial Hypertension, Pulmonary Hypertension and 2 more conditions. The registry lists an enrollment of 602 participants at 25 sites in 1 country. The registry lists a start date of 28 Feb 2005 and a primary completion date of 31 Jan 2016.

SponsorGeorgetown University →Enrollment602Pulmonary Arterial HypertensionPulmonary HypertensionSclerodermaSystemic Sclerosis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00377949
FieldValue
Registry IDNCT00377949
StatusCompleted
Study typeObservational study
Lead sponsorGeorgetown University
Enrollment602
Registered sites25
Countries1
ConditionsPulmonary Arterial Hypertension, Pulmonary Hypertension, Scleroderma and Systemic Sclerosis
Start28 Feb 2005
Primary completion31 Jan 2016
Last update posted3 May 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States2 sites
  • Ucla Medical Center

    Los Angeles

  • Stanford University

    Stanford

Colorado, United States1 site
  • National Jewish Medical and Research Center

    Denver

District of Columbia, United States1 site
  • Georgetown University Medical Center

    Washington D.C.

Illinois, United States2 sites
  • Northwestern University

    Chicago

  • University of Chicago

    Chicago

Louisiana, United States1 site
  • Louisiana State University Health Science Center

    New Orleans

Maryland, United States1 site
  • John Hopkins University Medical Center

    Baltimore

Massachusetts, United States3 sites
  • Boston University Medical School

    Boston

  • Tufts Medical Center

    Boston

  • University of Massachussetts Memorial Medical Center

    Worcester

Michigan, United States1 site
  • University of Michigan-Scleroderma Program

    Ann Arbor

Minnesota, United States2 sites
  • Hennepin County Medical Center

    Minneapolis

  • University of Minnesota

    Minneapolis

New Jersey, United States1 site
  • University of Medicine and Dentistry of New Jersey

    New Brunswick

New York, United States4 sites
  • Center for Rheumatology

    Albany

  • North Shore Long Island Jewish Medical Center

    New Hyde Park

  • Cornell University

    New York

  • Hospital for Special Surgery

    New York

Pennsylvania, United States2 sites
  • University of Pennsylvania

    Philadelphia

  • University of Pittsburgh

    Pittsburgh

South Carolina, United States1 site
  • Medical University of South Carolina

    Charleston

Texas, United States1 site
  • the University of Texas Health Science Center

    Houston

Utah, United States1 site
  • University of Utah

    Salt Lake City

Wisconsin, United States1 site
  • the Medical College of Wisconsin

    Milwaukee

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 2 sitesMN2Wisconsin: 1 siteWI1Michigan: 1 siteMI1New York: 4 sitesNY4Massachusetts: 3 sitesMA3Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinois: 2 sitesIL2IndianaINOhioOHPennsylvania: 2 sitesPA2New Jersey: 1 siteNJ1ConnecticutCTCalifornia: 2 sitesCA2NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtah: 1 siteUT1Colorado: 1 siteCO1KansasKSArkansasARTennesseeTNNorth CarolinaNCSouth Carolina: 1 siteSC1New MexicoNMOklahomaOKLouisiana: 1 siteLA1MississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of Columbia: 1 siteDC1
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00377949

Each answer restates registry values shown on this page.

What is NCT00377949?

NCT00377949 is an observational study sponsored by Georgetown University. It studies Pulmonary Arterial Hypertension, Pulmonary Hypertension and 2 more conditions.

Who leads NCT00377949?

The registry names Virginia D. Steen, MD (principal investigator, Georgetown University) as the overall official.

Where does NCT00377949 run?

The registry lists 25 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT00377949 end?

The registry lists a primary completion date of 31 Jan 2016. The sponsor last updated the record on 3 May 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.